Familial early-onset diabetes is not a typical MODY in several Tunisian patients
##plugins.themes.academic_pro.article.main##
Abstract
Background: MODY (Maturity-onset diabetes of the young), a dominantly inherited form of early-onset diabetes, is clinically and genetically heterogeneous with more than ten genetic subtypes described worldwide.
Aim: To evaluate the possible existence of MODY in 12 young diabetic Tunisian patients by searching for mutations in the most prevalent MODY genes.
Methods: Twelve patients with diabetes in 2-to-3 generations, all diagnosed before age 31, were screened for mutations and deletions in HNF1A, HNF4A, INS, IPF1, NEUROD1 and GCK genes by Sanger sequencing and by Multiplex ligation-dependent probe amplification assay.
Results: The patients had no evidence of autoimmunity and a mean age at diabetes diagnosis of 25.66 ± 3.96 years with severe overt diabetes (fasting glycaemia: 10.91 ± 3.55 mmol/ l; HbA1c: 10.46 ± 3.31 %). Two subjects were initially treated with insulin. On the ten initially treated with OHA or on diet, eight converted to insulin therapy (within 3 months to 20 years). Molecular analysis showed only one missense HNF4A mutation (I453V) in one family. No mutations in the studied genes were detected in the other patients.
Conclusion: A molecular defect in known MODY genes has been excluded in 11 patients with early-onset diabetes suggesting that other genetic causes may explain diabetes in these families. In such cases, new generation sequencing approaches may be well appropriate to identify specific molecular etiologies from extended families and to establish a strategy of molecular diagnostic of MODY in Tunisia.
Aim: To evaluate the possible existence of MODY in 12 young diabetic Tunisian patients by searching for mutations in the most prevalent MODY genes.
Methods: Twelve patients with diabetes in 2-to-3 generations, all diagnosed before age 31, were screened for mutations and deletions in HNF1A, HNF4A, INS, IPF1, NEUROD1 and GCK genes by Sanger sequencing and by Multiplex ligation-dependent probe amplification assay.
Results: The patients had no evidence of autoimmunity and a mean age at diabetes diagnosis of 25.66 ± 3.96 years with severe overt diabetes (fasting glycaemia: 10.91 ± 3.55 mmol/ l; HbA1c: 10.46 ± 3.31 %). Two subjects were initially treated with insulin. On the ten initially treated with OHA or on diet, eight converted to insulin therapy (within 3 months to 20 years). Molecular analysis showed only one missense HNF4A mutation (I453V) in one family. No mutations in the studied genes were detected in the other patients.
Conclusion: A molecular defect in known MODY genes has been excluded in 11 patients with early-onset diabetes suggesting that other genetic causes may explain diabetes in these families. In such cases, new generation sequencing approaches may be well appropriate to identify specific molecular etiologies from extended families and to establish a strategy of molecular diagnostic of MODY in Tunisia.
Keywords:
Early-onset diabetes, genetics, MODY, mutation, polymorphism, Tunisian population##plugins.themes.academic_pro.article.details##
References
- Vaxillaire M, Froguel P. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 2008; 29:254-64.
- Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 2011; 34:1878-84.
- Bowman P, Flanagan SE, Edghill EL et al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia 2012; 55:123-7.
- Bonnefond A, Philippe J, Durand E et al. Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene. PLoS One 2012; 7:e37423.
- Chevre JC, Hani EH, Boutin P et al. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 1998; 41:1017-23.
- Bouguerra R, Alberti H, Salem LB et al. The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr 2007; 61:160-5.
- Malecki MT, Yang Y, Antonellis A, Curtis S, Warram JH Krolewski AS. Identification of new mutations in the hepatocyte nuclear factor 4alpha gene among families with early onset Type 2 diabetes mellitus. Diabet Med 1999; 16:193-200.
- Harries LW, Locke JM, Shields B et al. The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development. Diabetes 2008; 57:1745-52.
- Eeckhoute J, Briche I, Kurowska M, Formstecher P, Laine B. Hepatocyte nuclear factor 4 alpha ligand binding and F domains mediate interaction and transcriptional synergy with the pancreatic islet LIM HD transcription factor Isl1. J Mol Biol 2006; 364:567-81.
- Urhammer SA, Hansen T, Ekstrom CT, Eiberg H, Pedersen O.The Ala/Val98 polymorphism of the hepatocyte nuclear factor- 1alpha gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: evidence from studies of 231 glucose-tolerant first degree relatives of type 2 diabetic probands. J Clin Endocrinol Metab 1998; 83:4506-9.
- Shaat N, Karlsson E, Lernmark A et al. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 2006; 49:1545-51.
- Cinek O, Drevinek P, Sumnik Z et al. NEUROD polymorphism Ala45Thr is associated with Type 1 diabetes mellitus in Czech children. Diabetes Res Clin Pract 2003; 60:49-56.
- Liu L, Jia W, Zheng T, Li M, Lu H, Xiang K. Ala45Thr variation in neuroD1 gene is associated with early-onset type 2 diabetes with or without diabetic pedigree in Chinese. Mol Cell Biochem 2006; 290:199-204.
- Bonnefond A, Froguel P, Vaxillaire M. The emerging genetics of type 2 diabetes. Trends Mol Med 2010; 16:407-16.
- Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 2012; 55:1265-72.
- Ellard S, Bellanne-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51:546-53.
- Bellanne-Chantelot C, Levy DJ, Carette C et al. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J Clin Endocrinol Metab 2011; 96:E1346-51.